论文部分内容阅读
按照美国新的药品条码管理规定,根据生产线的速度和不同的标签印刷需求,每条生产线上新设备的投资最高可达20万美元。2012年2月,美国多家医院发现假冒阿瓦斯汀(一种抗癌注射药物),这使得美国食品和药物管理局(FDA)允许药品制造商改变最小使用剂量或单个药品包装上条码的打印方式成为可能。10月,FDA宣布他们正在审查2004年的药品条码管理规定,该规定
According to the US new drug code management regulations, according to the speed of the production line and different label printing requirements, the investment for new equipment on each production line can reach up to 200,000 US dollars. In February 2012, counterfeit Avastin (an anti-cancer injectable drug) was discovered in multiple hospitals in the United States, which allowed the US Food and Drug Administration (FDA) to allow drug manufacturers to change the minimum use dose or print the bar code on a single drug package. Ways become possible. In October, the FDA announced that they are reviewing the 2004 drug bar code management regulations.